|
Volumn 367, Issue 9504, 2006, Pages 26-27
|
Authors' reply [6]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
PIOGLITAZONE;
PLACEBO;
TRIACYLGLYCEROL;
ACUTE CORONARY SYNDROME;
BLADDER CARCINOGENESIS;
BLOOD PRESSURE REGULATION;
BREAST CANCER;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG MECHANISM;
DRUG TOLERANCE;
GENOTOXICITY;
HEART FAILURE;
HEART INFARCTION;
HEMOGLOBIN DETERMINATION;
HUMAN;
LEG REVASCULARIZATION;
LETTER;
NONHUMAN;
PRIORITY JOURNAL;
RISK REDUCTION;
STROKE;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 29844457861
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(06)67915-4 Document Type: Letter |
Times cited : (1)
|
References (2)
|